Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001609410-16-000004
Filing Date
2016-09-02
Accepted
2016-09-02 11:39:06
Documents
1
Effectiveness Date
2016-09-02
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 11179
  Complete submission text file 0001609410-16-000004.txt   12365
Mailing Address 1617 JFK BLVD, SUITE #500 ONE PENN CENTER PHILADELPHIA PA 19103
Business Address 1617 JFK BLVD, SUITE #500 ONE PENN CENTER PHILADELPHIA PA 19103 215-988-0080
HEMISPHERX BIOPHARMA INC (Filer) CIK: 0000946644 (see all company filings)

EIN.: 520845822 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-270035 | Film No.: 161867622
SIC: 2836 Biological Products, (No Diagnostic Substances)